Advertisement
Canada markets close in 6 hours 25 minutes
  • S&P/TSX

    21,637.84
    -102.36 (-0.47%)
     
  • S&P 500

    5,061.82
    0.00 (0.00%)
     
  • DOW

    37,925.97
    +190.86 (+0.51%)
     
  • CAD/USD

    0.7230
    -0.0023 (-0.32%)
     
  • CRUDE OIL

    85.29
    -0.12 (-0.14%)
     
  • Bitcoin CAD

    87,042.95
    -4,455.99 (-4.87%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,393.70
    +10.70 (+0.45%)
     
  • RUSSELL 2000

    1,975.71
    -27.47 (-1.37%)
     
  • 10-Yr Bond

    4.6740
    +0.0460 (+0.99%)
     
  • NASDAQ

    15,863.96
    -21.06 (-0.13%)
     
  • VOLATILITY

    18.65
    -0.58 (-3.02%)
     
  • FTSE

    7,840.75
    -124.78 (-1.57%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • CAD/EUR

    0.6799
    -0.0025 (-0.37%)
     

Do Insiders Own Lots Of Shares In PureTech Health plc (LON:PRTC)?

Every investor in PureTech Health plc (LON:PRTC) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.

PureTech Health is a smaller company with a market capitalization of UK£557m, so it may still be flying under the radar of many institutional investors. Taking a look at our data on the ownership groups (below), it seems that institutions are noticeable on the share registry. We can zoom in on the different ownership groups, to learn more about PureTech Health.

Check out our latest analysis for PureTech Health

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About PureTech Health?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

ADVERTISEMENT

PureTech Health already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at PureTech Health's earnings history below. Of course, the future is what really matters.

earnings-and-revenue-growth
earnings-and-revenue-growth

Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. Our data indicates that hedge funds own 8.8% of PureTech Health. That catches my attention because hedge funds sometimes try to influence management, or bring about changes that will create near term value for shareholders. Invesco Ltd. is currently the largest shareholder, with 23% of shares outstanding. In comparison, the second and third largest shareholders hold about 10% and 8.8% of the stock. Furthermore, CEO Daphne Zohar is the owner of 4.4% of the company's shares.

We did some more digging and found that 6 of the top shareholders account for roughly 54% of the register, implying that along with larger shareholders, there are a few smaller shareholders, thereby balancing out each others interests somewhat.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

Insider Ownership Of PureTech Health

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

Shareholders would probably be interested to learn that insiders own shares in PureTech Health plc. It has a market capitalization of just UK£557m, and insiders have UK£42m worth of shares, in their own names. Some would say this shows alignment of interests between shareholders and the board. But it might be worth checking if those insiders have been selling.

General Public Ownership

The general public, who are usually individual investors, hold a 12% stake in PureTech Health. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Private Company Ownership

We can see that Private Companies own 3.5%, of the shares on issue. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Be aware that PureTech Health is showing 1 warning sign in our investment analysis , you should know about...

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here